June 11, 2024
Martin Tolar, MD, PhD
The president and CEO at Alzheon talked about the recent discoveries made in understanding the pathology of Alzheimer disease and the development of innovative therapies to potentially set the stage for more effective care.
WATCH TIME: 12 minutes
“The distinction between dementia and Alzheimer has been very difficult. The old diagnosis, which was based on collective symptoms, was about 30% wrong and has been a big problem for drug development.”